|
|
Rockeby Biomed Ltd - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for Rockeby Biomed Ltd Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Rockeby Biomed Ltd. The Group's principal activities are researching, developing and marketing rapid testing technologies for infectious disease in humans and animals and lifestyle health products including CanDia5 and Avian Influenza Virus test kits. It operates in Australia, Asia Pacific, Europe, Middle East and Africa.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|